$SBUX

BREWER BRADY sold $155K of SBUX

BREWER BRADY (ceo, International) sold 1,641 shares of STARBUCKS CORP (SBUX) at $94.33 ($0.15M total) on 2026-06-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · BREWER BRADY
Published Jun 9, 2026, 10:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 10:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SBUX
Neutral
high confidence
Mentioned
$SBUX
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SBUXNeutralLow
01

Why it matters

The CEO’s open-market sale (under a 10b5-1 plan) is a disclosure of ownership change, not a fundamental corporate event.

02

Market read

Traders may note the insider selling as a minor sentiment datapoint, but there is no new operational or financial information.

03

What to watch

The filing does not reveal intent beyond the pre-arranged plan; without context on total holdings, frequency of sales, or buy-side activity, signal quality is limited.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-09 (covers sale dated 2026-06-05)

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Starbucks.

Company-level read

Ticker impact

$SBUXNeutralHigh confidence
Context

Starbucks CEO Brewer Brady filed an open-market sale of 1,641 shares at $94.33 on 2026-06-05 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move from this filing alone; any reaction would be short-lived unless accompanied by other catalysts.

Evidence & confidence

Form 4 insider sales under pre-arranged 10b5-1 plans are typically less informative than unscheduled trades, and the article provides no new company-specific operational or financial development.

Market effects

Minimal—single-company insider transaction without accompanying guidance/earnings/regulatory developments.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with internal views on valuation; traders may still use it as a weak bearish sentiment input if positioning is crowded.

Key entities

  • STARBUCKS CORP

    Subject of the SEC Form 4 insider transaction disclosure.

  • BREWER BRADY

    Starbucks CEO, International; reported an open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SBUXHighAI 9/10

CEO Brian Niccol Just Announced Incredible News for Starbucks Investors

Starbucks (SBUX) reported its biggest-ever fall menu launch, with record sales for items like the Pumpkin Spice Latte. CEO Brian Niccol's turnaround efforts have led to four consecutive quarters of global same-store sales growth, with Q3 revenue at $9.3B and adjusted EPS up 70% to $0.85. The company raised its full-year 2026 outlook, guiding for 6%+ growth in U.S. and global comps. SBUX stock is up 24% YTD.

$SBUXLow

Flickinger added to Victoria's Secret board — Retail Technology Innovation Hub

Starbucks has appointed Andrew Corner as Senior Vice President of Supply Chain. He previously worked at Nike for nearly a decade, most recently as VP of Global Supply Chain & Planning Operations. Corner expressed gratitude for his time at Nike and enthusiasm for his new role at Starbucks. The 2026 RTIH Innovation Awards will focus on supply chain technology, with entries now open and the ceremony scheduled for November 4, 2026.

$PFEMed

Pfizer and Starbucks: One Turnaround Is Built to Last, and One Isn’t

Pfizer (PFE) beat revenue expectations for the 9th time in 10 quarters, with a 6.2% dividend yield and a 37x valuation multiple. Starbucks (SBUX) reported 7.9% comparable sales growth, raised 2026 EPS guidance, and offers a 2.3% yield with a 62x multiple. Pfizer's turnaround is further along in earnings, while Starbucks shows sales momentum. Both companies raised forward outlooks, indicating genuine recovery.

$SBUXMed

Starbucks Pumpkin Spice Latte Returns With 7 New Fall Drinks

Starbucks will launch its Pumpkin Spice Latte and seven new fall drinks on August 25, including pumpkin and banana bread-inspired beverages. The menu also features returning items like the Pumpkin Cream Cold Brew and new food options, such as a protein pocket. Additionally, a PSL merchandise collection will be available.